Sch 18640
| Internal ID | eb3c993c-00b3-4825-bdc4-3569646dc8fc |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[(1R,8S,11Z,15S,18S,25S,26R,35R,37S,40S,46S,51R,53S,59S)-37-[(2R)-butan-2-yl]-18-[(2R,3R)-2,3-dihydroxybutan-2-yl]-11-ethylidene-59-hydroxy-8-[(1R)-1-hydroxyethyl]-31-[(1S)-1-hydroxyethyl]-26,40,46-trimethyl-43-methylidene-6,9,16,28,38,41,44,47-octaoxo-23-sulfanylidene-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,54,57-undecaen-51-yl]-1,3-thiazole-4-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C72H87N19O17S6/c1-14-26(3)47-62(104)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)108-69(106)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-64(109)46-25-113-68(86-46)53(71(13,107)35(12)94)90-61(103)44-23-110-65(84-44)38(15-2)82-63(105)48(33(10)93)88-60(102)45-24-114-70(72)87-45/h15-17,20-22,24-26,30-35,39-40,44,47-49,51-53,79,81,92-95,107H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,104)(H,82,105)(H,88,102)(H,89,109)(H,90,103)(H,91,100)/b38-15-/t26-,30+,31+,32+,33-,34-,35-,39-,40-,44-,47+,48+,49+,51+,52-,53-,71+,72-/m1/s1 |
| InChI Key | AFAZQKILLUAQTN-DIPKEJMWSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C72H87N19O17S6 |
| Molecular Weight | 1683.00 g/mol |
| Exact Mass | 1681.4851594 g/mol |
| Topological Polar Surface Area (TPSA) | 716.00 Ų |
| XlogP | 0.90 |
| Atomic LogP (AlogP) | 1.15 |
| H-Bond Acceptor | 31 |
| H-Bond Donor | 18 |
| Rotatable Bonds | 12 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5853 | 58.53% |
| Caco-2 | - | 0.8601 | 86.01% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Mitochondria | 0.3971 | 39.71% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7996 | 79.96% |
| OATP1B3 inhibitior | + | 0.9330 | 93.30% |
| MATE1 inhibitior | - | 0.9046 | 90.46% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9570 | 95.70% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8670 | 86.70% |
| CYP3A4 substrate | + | 0.7641 | 76.41% |
| CYP2C9 substrate | - | 0.8079 | 80.79% |
| CYP2D6 substrate | - | 0.8481 | 84.81% |
| CYP3A4 inhibition | - | 0.7554 | 75.54% |
| CYP2C9 inhibition | - | 0.8620 | 86.20% |
| CYP2C19 inhibition | - | 0.8537 | 85.37% |
| CYP2D6 inhibition | - | 0.9081 | 90.81% |
| CYP1A2 inhibition | - | 0.8685 | 86.85% |
| CYP2C8 inhibition | + | 0.8738 | 87.38% |
| CYP inhibitory promiscuity | + | 0.5352 | 53.52% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.9700 | 97.00% |
| Carcinogenicity (trinary) | Non-required | 0.5373 | 53.73% |
| Eye corrosion | - | 0.9803 | 98.03% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7546 | 75.46% |
| Skin corrosion | - | 0.9138 | 91.38% |
| Ames mutagenesis | - | 0.5200 | 52.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7102 | 71.02% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | + | 0.5054 | 50.54% |
| skin sensitisation | - | 0.8147 | 81.47% |
| Respiratory toxicity | + | 0.8667 | 86.67% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9125 | 91.25% |
| Nephrotoxicity | - | 0.8482 | 84.82% |
| Acute Oral Toxicity (c) | III | 0.5704 | 57.04% |
| Estrogen receptor binding | - | 0.5966 | 59.66% |
| Androgen receptor binding | + | 0.8132 | 81.32% |
| Thyroid receptor binding | + | 0.8438 | 84.38% |
| Glucocorticoid receptor binding | + | 0.8924 | 89.24% |
| Aromatase binding | + | 0.8133 | 81.33% |
| PPAR gamma | + | 0.8579 | 85.79% |
| Honey bee toxicity | - | 0.5970 | 59.70% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
| Fish aquatic toxicity | + | 0.9709 | 97.09% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.80% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.09% | 96.09% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 98.83% | 93.03% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.76% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.37% | 91.11% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 98.32% | 95.71% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 97.50% | 85.14% |
| CHEMBL1293294 | P51151 | Ras-related protein Rab-9A | 95.94% | 87.67% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 95.63% | 86.33% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 95.54% | 92.88% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.51% | 88.42% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.49% | 96.61% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 95.37% | 95.69% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 95.05% | 89.34% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 94.05% | 90.17% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 93.93% | 99.29% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.84% | 90.71% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 92.46% | 83.10% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 92.25% | 91.24% |
| CHEMBL2581 | P07339 | Cathepsin D | 91.62% | 98.95% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 91.50% | 94.75% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 90.73% | 99.23% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 90.59% | 96.38% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 89.37% | 93.10% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 89.29% | 98.05% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 88.76% | 80.00% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 88.54% | 92.50% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.02% | 95.56% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 87.78% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.78% | 93.00% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 87.34% | 96.21% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.07% | 96.47% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 86.85% | 89.50% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 86.85% | 91.07% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 86.15% | 98.03% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 86.14% | 95.56% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 86.09% | 95.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.97% | 89.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 84.98% | 93.56% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 84.40% | 95.50% |
| CHEMBL1293277 | O15118 | Niemann-Pick C1 protein | 84.11% | 81.11% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 83.78% | 97.33% |
| CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 83.64% | 88.33% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 83.61% | 95.93% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.45% | 96.90% |
| CHEMBL4105838 | Q96GG9 | DCN1-like protein 1 | 82.74% | 95.00% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 82.40% | 89.63% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 82.30% | 92.29% |
| CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 82.12% | 92.62% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 81.92% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 81.69% | 97.09% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 81.65% | 94.00% |
| CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 81.60% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.38% | 97.14% |
| CHEMBL1075162 | Q13304 | Uracil nucleotide/cysteinyl leukotriene receptor | 81.26% | 80.33% |
| CHEMBL5028 | O14672 | ADAM10 | 80.69% | 97.50% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.23% | 91.19% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684538 |
| LOTUS | LTS0226248 |
| wikiData | Q104910871 |